US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Pharming Group NV (PHAR)
Pharming Group NV (PHAR) ニュース

PHAR

Pharming Group NV (PHAR)

Pharming Group NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PHAR

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/16	00 : 52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
2024/05/08	19 : 04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
2024/01/08	23 : 17	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
2023/10/26	22 : 25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
2023/08/24	15 : 00	PR Newswire (US)	Pharming Group to participate in September investor conferences	NASDAQ:PHAR	Pharming Group NV
2023/08/14	14 : 00	PR Newswire (US)	Pharming Group to convene Extraordinary General Meeting of Shareholders	NASDAQ:PHAR	Pharming Group NV
2023/08/09	14 : 00	PR Newswire (US)	Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan	NASDAQ:PHAR	Pharming Group NV
2023/08/09	14 : 00	PR Newswire (US)	Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan	NASDAQ:PHAR	Pharming Group NV
2023/08/04	00 : 09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
2023/08/03	14 : 00	PR Newswire (US)	Pharming Group reports second quarter and first half 2023 financial results	NASDAQ:PHAR	Pharming Group NV
2023/07/18	14 : 00	PR Newswire (US)	Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board	NASDAQ:PHAR	Pharming Group NV
2023/07/18	14 : 00	PR Newswire (US)	Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board	NASDAQ:PHAR	Pharming Group NV
2023/07/13	15 : 00	PR Newswire (US)	Pharming Group to report second quarter and first half 2023 financial results on August 3	NASDAQ:PHAR	Pharming Group NV
2023/07/13	15 : 00	PR Newswire (US)	Pharming Group to report second quarter and first half 2023 financial results on August 3	NASDAQ:PHAR	Pharming Group NV
2023/06/01	19 : 15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:PHAR	Pharming Group NV
2023/06/01	14 : 00	PR Newswire (US)	Pharming announces sale of priority review voucher	NASDAQ:PHAR	Pharming Group NV
2023/06/01	14 : 00	PR Newswire (US)	Pharming announces sale of priority review voucher	NASDAQ:PHAR	Pharming Group NV
2023/05/25	15 : 00	PR Newswire (US)	Pharming Group to attend the following Investor Conferences in June	NASDAQ:PHAR	Pharming Group NV
2023/05/25	15 : 00	PR Newswire (US)	Pharming Group to attend the following Investor Conferences in June	NASDAQ:PHAR	Pharming Group NV
2023/05/18	00 : 28	PR Newswire (US)	Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders	NASDAQ:PHAR	Pharming Group NV
2023/05/11	14 : 00	PR Newswire (US)	Pharming Group reports financial results for the first quarter of 2023	NASDAQ:PHAR	Pharming Group NV
2023/05/11	14 : 00	PR Newswire (US)	Pharming Group reports financial results for the first quarter of 2023	NASDAQ:PHAR	Pharming Group NV
2023/04/26	15 : 00	PR Newswire (US)	Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023	NASDAQ:PHAR	Pharming Group NV
2023/04/19	15 : 00	PR Newswire (US)	Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023	NASDAQ:PHAR	Pharming Group NV
2023/04/19	14 : 36	PR Newswire (US)	Notice of First Quarter 2023 Results	NASDAQ:PHAR	Pharming Group NV
2023/04/13	20 : 11	PR Newswire (US)	Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023	NASDAQ:PHAR	Pharming Group NV
2023/04/11	21 : 58	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:PHAR	Pharming Group NV
2023/04/11	14 : 00	PR Newswire (US)	Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.	NASDAQ:PHAR	Pharming Group NV
2023/04/11	14 : 00	PR Newswire (Canada)	Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.	NASDAQ:PHAR	Pharming Group NV
2023/04/11	14 : 00	PR Newswire (US)	Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.	NASDAQ:PHAR	Pharming Group NV

Showing the most relevant articles for your search:NASDAQ:PHAR

1 2 3 4 5 6 次へ >>

Global Uranium and Enric... (QB)

Societe Generale Effekten

ALPS Sector Dividend Dogs

General Assembly (PK)

State Street Global Advi...

Customers Bancorp

BNP Paribas Issuance

BNP Paribas Issuance

Amundi Luxembourg

Grayscale Stellar Lumens (QX)

Applied Materials

Brussels Capital Bond un...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約